3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hematopoietic and Lymphatic System Neoplasm
3
Neoplasms
2
Malignant Solid Neoplasm
2
Lung Neoplasms
2
Breast Neoplasms
2
Spondylitis, Ankylosing
1
Smoking Cessation
1
Sarcoma
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Obesity
1
Mouth Neoplasms
1
Mental Disorders
1
Melanoma
1
Malignant Female Reproductive System Neoplasm
1
Lupus Erythematosus, Systemic
1
Localized Head and Neck Carcinoma
1
Laryngeal Neoplasms
1
Inflammatory Bowel Diseases
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Depressive Disorder
1
Depression
1
Crohn Disease
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Specimen Handling
16
Magnetic Resonance Spectroscopy
15
Gemcitabine
14
pembrolizumab
11
Cisplatin
11
Mitomycin
7
Radiation
6
Fluorouracil
6
Cystoscopy
6
enfortumab vedotin
5
avelumab
5
Biopsy
5
dehydroftorafur
4
Transurethral Resection of Bladder
4
Radiotherapy
4
Platinum
4
Nivolumab
4
Mitozytrex
4
Carboplatin
4
1,2-diaminocyclohexaneplatinum II citrate
4
erdafitinib
3
durvalumab
3
cabozantinib
3
Immunoglobulin G
3
Disulfides
3
sapanisertib
2
olaparib
2
eribulin
2
atezolizumab
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Interviews as Topic
×
30 days
×
Clear all
No trials found.